John Hopkins University Archives

About Us

Bharti Rana Jayshankar – Founder

She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.

Jay Shankar – Co-founder

He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.

Contact Info

info@healthquill.com

WHO issues global warning on drug-resistant Klebsiella Pneumonie pathogen

WHO warns on drug-resistant Klebsiella Pneumonie spread

HQ Team August 4, 2024: The WHO has warned about the rising global incidence of hypervirulent and multi-resistant Klebsiella Pneumoniae (hvKp) infections. The.

by HealthQuill
August 4, 2024
0 Comments

Vertex Pharmaceuticals, a US-based biotechnology company, announced its mid-stage trial on a non-opioid oral drug for patients with diabetic peripheral neuropathy has yielded positive results.

Drugs Health Pharma

Drug trials for diabetic peripheral neuropathy ‘positive’: Vertex

HQ Team December 13, 2023: Vertex Pharmaceuticals, a US-based biotechnology company, announced its mid-stage trial on a non-opioid oral drug for patients with.

by HealthQuill
December 13, 2023
0 Comments